Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
6.38
-0.31 (-4.63%)
At close: Jan 23, 2026, 4:00 PM EST
6.40
+0.02 (0.32%)
After-hours: Jan 23, 2026, 7:10 PM EST

Verastem Revenue

Verastem had revenue of $11.24M in the quarter ending September 30, 2025. In the year 2024, Verastem had annual revenue of $10.00M.

Revenue (ttm)
$10.00M
Revenue Growth
+33.79%
P/S Ratio
28.91
Revenue / Employee
$171,526
Employees
78
Market Cap
492.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vanda Pharmaceuticals212.07M
Niagen Bioscience124.71M
Zevra Therapeutics84.39M
Bicycle Therapeutics28.34M
Aclaris Therapeutics15.74M
Prothena Corporation11.79M
Ocugen5.37M
Lyell Immunopharma41.00K
Revenue Rankings

VSTM News

More News